Mark Turner joined the London-based private equity firm, Livingbridge LLP, as a founding partner in 2001. He is currently Head of the Value Strategy Group, overseeing operations in the US. He also sits on the firm's Management Committee, which focuses on the strategic direction of the business.
Mark has led the value creation strategy in many investments including YSC, Americana, William Medical and Encore Tickets. He currently sits on the boards of Jensten, Adarma, M247 and The Up Group.
As a Banking and Finance graduate and a qualified Chartered Accountant, Mark has wide-ranging experience in both corporate advisory roles and in industry, working in corporate restructuring at Deloitte and acquisition integration and business planning roles at BT and Global Crossing.